Drug Res (Stuttg) 2013; 63(09): 473-476
DOI: 10.1055/s-0033-1345183
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

A Reliable Method to Quantify Sildenafil and its Metabolite N-Demethylsildenafil by HPLC in Plasma of Children

B. Ramírez-Mendiola
1   Laboratorio de Farmacología, Instituto Nacional de Pediatría, Mexico City, Mexico
,
C. Flores-Pérez
1   Laboratorio de Farmacología, Instituto Nacional de Pediatría, Mexico City, Mexico
,
R. García-Álvarez
1   Laboratorio de Farmacología, Instituto Nacional de Pediatría, Mexico City, Mexico
,
H. Juárez-Olguín
1   Laboratorio de Farmacología, Instituto Nacional de Pediatría, Mexico City, Mexico
2   Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
,
J. Flores-Pérez
1   Laboratorio de Farmacología, Instituto Nacional de Pediatría, Mexico City, Mexico
2   Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
,
J. L. Chávez Pacheco
1   Laboratorio de Farmacología, Instituto Nacional de Pediatría, Mexico City, Mexico
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 29. Januar 2013

accepted 25. April 2013

Publikationsdatum:
04. Juni 2013 (online)

Abstract

The aim of this study was to develop a simple method for quantifying plasma levels of sildenafil and its metabolite by liquid chromatography with a C18 reverse-phase column and UV detection. For both compounds, linearity was assessed in the range from 10 and 1 000 ng · ml−1 and had correlation coefficients of r=0.995 and r=0.997 for sildenafil and its metabolite, respectively. The inter- and intra-day coefficients of variation was<5.3%. The limits of detection and quantification were 1 and 10 ng · ml−1. Drug levels were determined satisfactorily in two patients. A simple and reliable method was developed for use in children with Pulmonary Arterial Hypertension under treatment with sildenafil.

 
  • References

  • 1 Turko I, Ballard S, Francis S et al. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds. Mol Pharmacol 1999; 56: 124-130
  • 2 Fox W, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatric 1983; 103: 505-514
  • 3 Leibovitch L, Matok I, Paret G. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension. Drugs 2007; 67: 57-73
  • 4 Sola A, Baquero H. Oral sildenafil in neonatal medicine: tested in adults also used in neonates. An Pediatr 2007; 66: 167-176
  • 5 Donoso F, Moro M. Persistent pulmonary hypertension. Ann Esp Pediatr 1990; 33: 101-105
  • 6 Farreras P, Rozman C Medicina Interna 14° ed Mosby/Doyma 956-958
  • 7 Guermouche M, Bensalah K. Solid phase extraction and liquid chromatographic determination of sildenafil and N-demethylsildenafil in rat serum with basic mobile phase. J Pharma Biomed Anal 2006; 40: 952-957
  • 8 Ghazawi M, Tutunji M, Abu Ruz S. Simultaneous determination of sildenafil and N-desmethyl sildenafil in human plasma by high-performance liquid chromatography method using electrochemical detection with application to a pharmacokinetic study. J Pharma Biomed Anal 2007; 43: 613-618
  • 9 Herrera R, González C, Castillo H et al. Sildenafil oral como alternativa en el tratamiento de recién nacidos con hipertensión pulmonar persistente. Rev Mex Pediatr 2006; 73: 159-163
  • 10 Crespo C, Morales V, Alonso H et al. Primary pulmonary hypertension and its management. Farm Hosp 2004; 28: 48-55
  • 11 Ming-Thua S, An-Bang W, Geng-Cheng Y. Development of a liquid chromatographic method for bioanalytical applications with sildenafil. J Chromatogr B 2003; 791: 255-262
  • 12 Joo YC, Hyeonh SL, Kyung SY et al. Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine. J Chromatogr B 2003; 795: 179-186
  • 13 Lin J, Strauss R, Kulhavy J et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 2000; 106: E19
  • 14 McPherson R. Blood sample volumes: emerging trends in clinical practice and laboratory medicine. Clin Leadership Manag Rev 2001; 15: 3-10
  • 15 Norma Oficial Mexicana NOM-117-SSA1-1998. Validación de métodos analíticos para estudios de bioequivalencia. In: Diario Oficial de la Federación, 1999
  • 16 Analytical Procedures and Methods Validation . Chemistry, Manufacturing, and Controls Documentation. Center for Drug Evaluation and Research (CDER). Food and Drug Administration; US, 5630, Fishers Lane, rm. 1061 Rockville, MD: 20852. August 2000
  • 17 Miller JC, Miller JN. Statistics for Analytic Chemistry. 3rd ed. Ellis Horwood; Chichester: 1993
  • 18 Ramírez-Mendiola B, Rivera-Espinosa L, Chávez-Pacheco JL et al. Stability, content uniformity and therapeutic efficacy of sildenafil extemporaneous capsules. African J Pharm Pharmacol 2012; 6: 162-168